Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4… Grant US-11292840-B2 United States of America 05 Apr 2022
Gene signatures for determining ICOS expression Grant US-10968277-B2 United States of America 06 Apr 2021
NOVEL ICOS ANTIBODIES AND TUMOR-TARGETED ANTIGEN BINDING MOLECULES COMPRISING THEM Application WO-2020260326-A1 World Intellectual Property Organisation (WIPO) 30 Dec 2020
COMBINED THERAPY WITH ICOS BINDING PROTEINS AND ARGININEMETHYLTRANSFERASE INHIBITORS Application WO-2019229613-A1 World Intellectual Property Organisation (WIPO) 05 Dec 2019
COMBINATION OF A TYPE II PROTEIN ARGININE METHYLTRANSFERASE INHIBITOR AND AN ICOS BINDING… Application WO-2019229614-A1 World Intellectual Property Organisation (WIPO) 05 Dec 2019
METHODS FOR PURIFYING ANTIBODIES Application WO-2019171294-A1 World Intellectual Property Organisation (WIPO) 12 Sep 2019
COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BISPECIFIC MOLECULES Application WO-2019122049-A1 World Intellectual Property Organisation (WIPO) 27 Jun 2019
COMBINATION THERAPY OF TUMOR TARGETED ICOS AGONISTS WITH T-CELL BISPECIFIC MOLECULES Application EP-3502140-A1 European Patent Office 26 Jun 2019
Combination immunotherapy for the treatment of cancer Grant US-10167337-B2 United States of America 01 Jan 2019
Combination immunotherapy for the treatment of cancer Grant US-10023637-B2 United States of America 17 Jul 2018
ANTI-ICOS AND ANTI-PD-1 ANTIBODY COMBINATION THERAPY Application WO-2018025221-A1 World Intellectual Property Organisation (WIPO) 08 Feb 2018
COMBINATION THERAPY COMPRISING ANTI CTLA-4 ANTIBODIES Application WO-2017025871-A1 World Intellectual Property Organisation (WIPO) 16 Feb 2017
AGONISTIC ICOS BINDING PROTEINS Application WO-2016120789-A1 World Intellectual Property Organisation (WIPO) 04 Aug 2016
Combination immunotherapy for the treatment of cancer Grant US-9375475-B2 United States of America 28 Jun 2016